Jump Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Jump Financial’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-143,439	Closed	-$588K	–	2175
2022 Q1	$588K	Buy	+143,439	New	+$520K	0.03%	734
2021 Q3	–	Sell	-22,900	Closed	-$100K	–	1649
2021 Q2	$100K	Buy	+22,900	New	+$93.3K	0.01%	978

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jump Financial's ATRS Position: Q2 2022 in Review

Jump Financial sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 143,439 shares — an estimated $588K sold.

Jump Financial first reported a position in ATRS in Q2 2021 and held it in 2 quarters. The position peaked at $588K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Jump Financial reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Jump Financial sold 143,439 Antares Pharma, Inc. shares in Q2 2022, an estimated $588K.
Jump Financial first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 2 quarters.
Jump Financial's Antares Pharma, Inc. position peaked at $588K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Jump Financial's 13F filing for Q2 2022, filed 9 Aug 2022.